Kevin Hern sold Novartis AG ADR (NYSE: NVS)
Kevin Hern (R-OK), a U.S. Representative, has disclosed 2 trades in Novartis AG ADR (NVS) since 2020, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Kevin Hern sold $1,001 - $15,000 of Novartis AG ADR (NYSE: NVS) on January 31, 2023. Since that trade, NVS is up +102.86% against the S&P 500 up +87.20%, an outperformance of +15.65%.
Across these filings, Kevin Hern has been a balanced trader of NVS (a buy-to-sell ratio of 1.00). Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Kevin Hern's NVS trades vs the price
NVS is up +102.86% since Kevin Hern sold on January 31, 2023, versus +87.20% for the S&P 500.
Performance since this trade
All Kevin Hern NVS trades
Kevin Hern & NVS trading FAQ
Is it legal for Kevin Hern to trade Novartis AG ADR (NVS) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Novartis AG ADR (NVS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Kevin Hern sell NVS?
Kevin Hern disclosed a sale of $1,001 - $15,000 of Novartis AG ADR (NVS) on January 31, 2023, according to public STOCK Act filings.
How has NVS performed since Kevin Hern's trade?
Since Kevin Hern sold NVS on January 31, 2023, the stock is up +102.86%, versus +87.20% for the S&P 500 over the same period, an outperformance of +15.65%.
How many times has Kevin Hern traded NVS?
Kevin Hern has disclosed 2 NVS trades since 2020 (1 purchase and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NVS trades?
Quantellect tracks every disclosed congressional trade in Novartis AG ADR (NVS) on the Novartis AG ADR congressional trading page, which aggregates filings across all members of Congress.
Kevin Hern's NVS tradesAll congressional filings for Novartis AG ADRKevin Hern's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.